Campylobacter-associated hospitalisations in an Australian provincial setting

BMC Infectious Diseases

Table 2 Comparison of signs, symptoms, and other outcomes among Campylobacter-associated admissions with and without documented comorbidities (as per Charlson Co-morbidity Index)

	Comorbidity present (n = 237)
Signs and symptoms associated with enterocolitis	Yes	%	No	%	Total	Χ²	p-value
Diarrhoea	231	98.7	444	99.1	675	0.23	0.63
Bloody diarrhoea	28	18.7	121	35.2	149	13.51	< 0.001
Self-reported fever	129	58.1	341	78.0	470	28.57	< 0.001
Fever (≥38 °C)	114	50.0	224	51.4	338	0.11	0.74
Abdominal pain	161	81.7	403	95.7	564	33.00	< 0.001
Nausea	142	79.8	311	87.6	453	5.70	0.02
Vomiting	114	58.8	234	56.5	348	0.27	0.60
Myalgia / arthralgia	35	76.1	122	87.1	157	3.22	0.07
Malaise	102	91.9	152	96.8	254	3.18	0.07
Headache	53	66.3	149	89.8	202	20.31	< 0.001
Key signs and symptoms of infection
Hypotension	52	22.3	35	7.8	87	27.94	< 0.001
Tachycardia	89	38.2	152	33.9	241	1.22	0.27
Electrolyte imbalance	169	72.5	241	53.8	410	22.46	< 0.001
Renal impairment	98	42.1	29	6.5	127	127.95	< 0.001
Acute confusion	34	14.6	4	0.9	38	54.60	< 0.001
Bacteraemia	17	7.2	11	2.5	28	8.80	< 0.01
Other outcomes
ICU admission	10	4.2	0	–	10		< 0.001^a
Death within 28 days of discharge	5	2.1	0	–	5		< 0.01^a
Campylobacter-associated readmission	22	9.3	16	3.6	38	9.65	0.002

ISSN: 1471-2334